David Charles Lubner, Director at POINT Biopharma Global Inc. (PNT), bought 3,600 shares at $6.85 ($25K) on 2022-11-23, disclosed to the SEC on 2022-11-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TTPH | SELL | 2015-08-17 | $408K | — | Filing → |
| TTPH | SELL | 2015-07-15 | $367K | — | Filing → |
| TTPH | SELL | 2015-06-16 | $725K | — | Filing → |